CHEK2 and prostate carcinoma: In the following, we provide an overview of the current knowledge of the role of a genetic variant, 1100delC, of CHEK2 in prostate cancer risk along with a meta-analysis and discuss the implication for potential translation of this knowledge into clinical practice.